Crossing the borders of innovationBasing clinical trials on sound mechanistic and scientific rationale. Cancer Patients are fighting for their lives...we will fight with themImagining a world without cancer.At Apollomics, Purpose Drives ActionPursuing a global vision of healing for all. Apollomics is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies. Pipeline Science Events Our Vision To become a global leader in the development of novel medicines for cancer patients. Learn More Recent News January 6, 2020 GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China May 17, 2019 **Media Alert** Foster City Mayor Welcomes Apollomics, Inc. to Their New Headquarters More News
